Given that PON1 hydrolyses OPs and ability to detoxify them is largely determined by its different variants [181], it is assumed that the individual risk of developing ALS after exposure to OPs could grow in case of genetic mutations and suboptimal body concentration of PON1 [182,183]. This evidence concerns the gene PON1 and amyotrophic lateral sclerosis.